Share meeting
Файлы
1.Agrees to amend paragraph 6 of the review process for entries in the Register of Specific Exemptions1 to read as follows:“6. This review process will be open-ended. It will continue to be reviewed, as necessary, by the Conference of the Parties as part of its consideration of specific exemptions and amended as the Conference of the Parties deems appropriate.”;
2.Notes, pursuant to paragraph 9 of Article 4, that as there are no longer any parties registered for specific exemptions for the production and use of perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl fluoride for carpets, leather and apparel, textiles and upholstery, paper and packaging, coatings and coating additives and rubber and plastics, no new registrations may be made with respect to them;
4.Encourages parties to take into consideration the report of the expert consultation on the review of lindane and alternatives in the treatment of head lice and scabies when promoting alternatives to lindane;2
5.Reminds the parties that may wish to register for specific exemptions for hexabromocyclododecane and technical endosulfan and its related isomers to notify the Secretariat in accordance with Article 4;
6.Also reminds the parties that may wish to register for acceptable purposes, articles in use and closed-system site-limited intermediates that are currently available to notify the Secretariat using the relevant forms for notifications;3
7.Notes that, on the basis of the notification submitted to the Secretariat by India on 10 March 2014, the production and use of DDT as a closed-system site-limited intermediate in the production of dicofol has been extended until 15 May 2024;